INTS : Recherche

Votre recherche : [La BTT] AUTEUR égal Stieltjes N
5 résultat(s)

Stieltjes N, Torchet MF, Misrahi L, Roussel-Robert V, Lambert L, Guérois C, Bertrand MA, Briquel ME, Borel-Derlon A, Dirat G. Epidemiology survey of haemophiliacs with inhibitors in France : orthopaedic status, quality of life and cost - The 'statut orthopédique des patients hémophiles' avec inhibiteur study. Blood Coagul Fibrinolysis. 2009;20:4-11.
Thèmes : Coagulation et fibrinolyse ; maj-2009-04

Berezné A, Stieltjes N, Le-Guern V, Teixeira L, Billy C, Roussel-Robert V, Flaujac C, Horellou MH, Guillevin L, Mouthon L. Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases. Transfus Med. 2006;16:209-212.
Thèmes : Plasma et dérivés plasmatiques ; Coagulation et fibrinolyse ; maj-2006-09

Slaoui M, Lambert T, Stieltjes N, Claeyssens S, Borel-Derlon A. Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors: a report of five cases. Blood Coagul Fibrinolysis. 2004;15:687-691.
Thèmes : Thérapeutiques de substitution - Facteurs de croissance ; maj-2005-01

Lacroix-Desmazes S, Bayry J, Misra N, Horn MP, Villard S, Pashov A, Stieltjes N, d'Oiron R, Saint-Remy JM, Hoebeke J, Kazatchkine MD, Reinbolt J, Mohanty D, Kaveri SV. The prevalence of proteolytic antibodies against factor VIII in hemophilia A. N Engl J Med. 2002;346:662-667.
Thèmes : Coagulation et fibrinolyse

Moreau A, Lacroix-Desmazes S, Stieltjes N, Saenko E, Kaveri SV, d'Oiron R, Sultan Y, Scandella D, Kazatchkine MD. Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG. Blood. 2000;95:3435-3441.
Thèmes : Coagulation et fibrinolyse